Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.

Saved in:
Bibliographic Details
Title: Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple Sclerosis.
Authors: Grigoriadou E; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Polyzoidou E; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Bakirtzis C; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Mylonas C; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Kesidou E; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Tatsi T; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Nteli E; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Konstantinidou N; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Styliadis C; Laboratory of Medical Physics and Digital Innovation, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece., Vrienniou A; Hellenic Federation of Persons with Multiple Sclerosis (HFoPwMS), Athens, Greece., Papazisis G; Department of Clinical Pharmacology, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece., Bamidis P; Laboratory of Medical Physics and Digital Innovation, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece., Boziki MK; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece., Grigoriadis NC; 2nd Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece.; Hellenic Academy of Neuroimmunology (HEL.A.NI.), Thessaloniki, Greece.
Source: Frontiers in public health [Front Public Health] 2026 Apr 21; Vol. 14, pp. 1801437. Date of Electronic Publication: 2026 Apr 21 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2296-2565
DOI:10.3389/fpubh.2026.1801437